A bivalent nanoparticle vaccine exhibits potent cross-protection against the variants of SARS-CoV-2

Inoculation against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is ongoing worldwide. However, the emergence of SARS-CoV-2 variants could cause immune evasion. We developed a bivalent nanoparticle vaccine that displays the receptor binding domains (RBDs) of the D614G and B.1.351 str...

Descripción completa

Detalles Bibliográficos
Autores principales: Yuan, Yaochang, Zhang, Xiantao, Chen, Ran, Li, Yuzhuang, Wu, Bolin, Li, Rong, Zou, Fan, Ma, Xiancai, Wang, Xuemei, Chen, Qier, Deng, Jieyi, Zhang, Yongli, Chen, Tao, Lin, Yingtong, Yan, Shumei, Zhang, Xu, Li, Congrong, Bu, Xiuqing, Peng, Yi, Ke, Changwen, Deng, Kai, Pan, Ting, He, Xin, Zhang, Yiwen, Zhang, Hui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. 2022
Materias:
Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8695190/
https://www.ncbi.nlm.nih.gov/pubmed/34990583
http://dx.doi.org/10.1016/j.celrep.2021.110256

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8695190/
https://www.ncbi.nlm.nih.gov/pubmed/34990583
http://dx.doi.org/10.1016/j.celrep.2021.110256

Ejemplares similares